v3.22.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 14,584,715 $ 8,053,879
Short-term investments 69,528,419 88,324,922
Accounts receivable 99,705 66,049
Prepaid expenses and other current assets 2,364,918 2,886,520
Total Current Assets 86,577,757 99,331,370
Property and Equipment, net 3,098,665 2,158,479
Other Assets.    
In-process R&D 3,500,000 3,500,000
Grant receivable 1,524,522 1,318,359
Operating lease right-of-use asset 1,954,205 1,782,884
Finance lease right-of-use asset 407,839 470,700
Other assets 16,995,227 12,193,540
Deposits 208,307 205,901
Total Other Assets 24,590,100 19,471,384
Total Assets 114,266,522 120,961,233
Current Liabilities    
Accounts payable 2,228,192 922,782
Operating lease liability, current portion 420,460 350,343
Finance lease liability, current portion 244,163 260,574
Accrued expenses and other liabilities 1,644,200 2,419,676
Contingent consideration, current portion 600,866 593,037
Contingent consideration, related party - current portion 176,634 174,333
Total Current Liabilities 5,314,515 4,720,745
Long Term Liabilities    
Other long-term liabilities 55,080 53,530
Derivative warrant liability 3,241 11,020
Deferred tax liability 215,937 215,937
Deferred revenue, net of current portion 35,000 35,000
Operating lease liability, net of current portion 1,183,597 1,060,856
Financing lease liability, net of current portion 216,649 255,429
Contingent consideration 1,966,060 1,990,118
Contingent consideration, related party 577,955 585,027
Total Liabilities 9,568,034 8,927,662
Commitments and Contingencies
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,649,824 and 25,649,824 shares issued and outstanding at March 31, 2022 and December 31, 2021 5,120 5,055
Additional paid-in capital 279,800,072 278,890,153
Accumulated deficit (173,839,540) (165,718,953)
Accumulated other comprehensive loss (123,210) (67,941)
Total Stockholders' Equity - NightHawk Biosciences, Inc. 105,842,442 113,108,314
Non-Controlling Interest (1,143,954) (1,074,743)
Total Stockholders' Equity 104,698,488 112,033,571
Total Liabilities and Stockholders' Equity $ 114,266,522 $ 120,961,233

Source